GRN-1201

N/A

Report date: 2023/08/09 19:30:36

Base Information

Drug NameGRN-1201
Drug Alias NameGRN-1201
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGreenpeptide
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrightpath Biotherapeutics Co Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungMelanoma

Other Information

ATC CodeN/A
Related LinksN/A